Novavax (NVAX)
(Delayed Data from NSDQ)
$11.99 USD
+0.03 (0.25%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $11.96 -0.03 (-0.25%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for Novavax, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 984 | 1,982 | 1,146 | 476 | 19 |
Cost Of Goods | 344 | 903 | 0 | 0 | 0 |
Gross Profit | 640 | 1,079 | 1,146 | 476 | 19 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,206 | 1,724 | 2,833 | 892 | 139 |
Income After Depreciation & Amortization | -567 | -645 | -1,687 | -417 | -121 |
Non-Operating Income | 38 | 11 | -7 | 14 | 2 |
Interest Expense | 14 | 20 | 21 | 15 | 14 |
Pretax Income | -543 | -654 | -1,715 | -418 | -133 |
Income Taxes | 2 | 4 | 29 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -545 | -658 | -1,744 | -418 | -133 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -545 | -658 | -1,744 | -418 | -133 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -525 | -616 | -1,674 | -410 | -113 |
Depreciation & Amortization (Cash Flow) | 41 | 29 | 13 | 6 | 7 |
Income After Depreciation & Amortization | -567 | -645 | -1,687 | -417 | -121 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 100.77 | 78.18 | 74.40 | 57.55 | 24.10 |
Diluted EPS Before Non-Recurring Items | -5.41 | -8.42 | -23.44 | -7.27 | -5.80 |
Diluted Net EPS (GAAP) | -5.41 | -8.42 | -23.44 | -7.27 | -5.51 |
Fiscal Year end for Novavax, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 415.48 | 93.86 | 291.34 | 186.99 | 424.43 |
Cost Of Goods | 46.24 | 59.21 | 154.98 | 98.93 | 55.78 |
Gross Profit | 369.24 | 34.65 | 136.37 | 88.06 | 368.65 |
SG&A, R&D, and Dept/Amort Expenses | 208.25 | 179.48 | 319.94 | 213.69 | 313.20 |
Income After SG&A, R&D, and Dept/Amort Expenses | 160.99 | -144.83 | -183.57 | -125.63 | 55.45 |
Non-Operating Income | 7.73 | 3.65 | 10.98 | -2.98 | 5.53 |
Interest Expense | 4.14 | 4.11 | 4.12 | 2.86 | 3.12 |
Pretax Income | 164.59 | -145.29 | -176.70 | -131.47 | 57.87 |
Income Taxes | 2.21 | 2.26 | 1.69 | -0.70 | -0.14 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 162.38 | -147.55 | -178.39 | -130.78 | 58.01 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 162.38 | -147.55 | -178.39 | -130.78 | 58.01 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 165.86 | 139.92 | 123.68 | 103.43 | 104.07 |
Diluted EPS Before Non-Recurring Items | 0.99 | -1.05 | -1.44 | -1.26 | 0.58 |
Diluted Net EPS (GAAP) | 0.99 | -1.05 | -1.32 | -1.26 | 0.58 |